Crane: Record Backlog, Record Margin, Discounted Stock

The industrial compounder is executing better than its share price, but the acquisition math and a 12% drawdown are now the real debate.

CR · Earnings Call · 2026-10-28

Record quarter, but the real news is the accretion clock

Crane's Q3 was another record: 8% core sales growth, total sales up 28%, adjusted operating margin of 22.5%, and a record backlog up 9% year over year. That backlog is part of a broader industrial trade — the global tape shows record backlog levels among 360-day advancers — so the backlog itself is not the differentiated signal. The differentiated signal is what Crane is doing with the acquired assets. Alex Alcala raised the 2026 EPS contribution from the four acquisitions to roughly $0.30 from $0.20: “We expect these acquisitions to contribute approximately $0.30 per share to 2026 earnings. Up from our previous expectation of $0.20 per share.” — Alejandro Alcala, President and Chief Executive Officer · 2026-10-28 That is the third upgrade in three quarters. In April, Richard Maue framed the full-year number at 15 cents: “Coming into the year, we had about an 8-cent number in mind, and we felt comfortable today saying that we would see a full year of 15 cents.” — Richard A. Maue, Chief Financial Officer · 2026-04-28 By July, Alex was already saying the PSI businesses would reach the 10% ROIC hurdle faster: “We are definitely going to get there faster... ahead of schedule by maybe one-and-a-half years.” — Alex Alcala, President and Chief Executive Officer · 2026-07-29 The current call confirms that timeline — 18 months early — and raises the earnings contribution again. This is not a demand story anymore; it is a Crane Business System integration story. The operating proof is in the segments. PFT core sales rose 6.2%, orders jumped 20% year over year and 8% sequentially, and segment margin hit a record 24%. AAT core sales rose 9.5%, margin was 26.3%, and backlog reached nearly $1.3 billion. Richard's order bridge is worth keeping: “Core orders increased 11% year over year with continued strength in aerospace and advanced technologies, up 2% as expected and when excluding a multiyear order received in the same period last year were up in the mid teens and process flow technologies up an exceptional 20%.” — Richard A. Maue, Executive (likely CFO or similar senior executive) · 2026-10-28 The mix matters: PFT, the segment that was the laggard, is now the order engine.

PFT gets a new shape: Trillium in, Building Services out

The portfolio surgery is the second change. Crane announced the acquisition of Trillium Pumps and the divestiture of Building Services and Utilities. Alex framed it as a deliberate narrowing:

Together, these actions continue to reposition PFT around highly engineered mission critical technologies. Serving attractive growth markets, including pharmaceuticals, water and wastewater, power, cryogenics, and nuclear.
Alejandro Alcala, President and Chief Executive Officer · 2026-10-28

The financial math is modest but telling. Building Services is roughly $160 million of revenue at fleet-average margin; Trillium is $115 million at below-fleet-average margin. The company expects the sale to close near the end of Q1, so 2027 will carry a partial-year dilution that Trillium should mostly offset. This is not a needle-moving deal on day one. It is a signal about where Crane wants PFT to live. The end-market mix has already moved. Chemical was once about 30% of PFT; it is now close to 20%. Water and wastewater is 14% to 15%, general industrial about 20%, and power — gas plus nuclear — about 15%. Management is explicitly trying to break the old chemical-cycle association. Alex said chemical is still flat, but “that is not the case anymore in PFT. So that chemical recovery is all upside still.” — Alejandro Alcala, President and Chief Executive Officer · 2026-10-28 That is a shift from April, when he was careful not to call a turn: “we are not quite calling an inflection, especially on chemicals.” — Alejandro A. Alcala, President and Chief Executive Officer · 2026-04-28 The keyword chemical recovery still appears in the quarter's top themes, but the message is now that Crane does not need it. Instead, the growth is in reshoring activity in U.S. pharma, Space Launch-driven cryogenics, wastewater, and gas-fired power.

The defense kicker and the discounting tape

Aerospace and defense remains the cleanest growth vector. The missile business is small today — about $35 million across roughly 15 programs — but Alex expects 40% to 50% growth next year and a 4x to 6x expansion of that base by the end of the decade. “A lot of that demand is already in the backlog. And then the projections after that 4x to 6x growth of that $35 million base, I think, is where these contracts come into play.” — Alejandro Alcala, President and Chief Executive Officer · 2026-10-28 The content is in advanced power conversion and microwave products, and management says capacity is not the constraint. That is real optionality, but it is still optionality off a small base. The stock is the puzzle. Crane is 12.4% below its July 27 peak and down 6.8% over the last 90 trading days, even as the company prints record revenue, record margin, and record backlog. On the last filed quarter, the shares carry a 38.4x price-to-net-income multiple and a 5.0x price-to-revenue multiple. That is not a cheap stock. The balance sheet has also changed: the Q2 filing shows effective net cash of -$748 million, with liabilities at 45.9% of assets and interest coverage of 8.7x. Management repaid $170 million of debt in Q3 and puts pro forma net leverage at 1.1x, so this is not a stretched balance sheet. But Crane is no longer the net-cash compounder it was a year ago. That is the tension worth watching. The operating story is getting better: PFT is growing again, acquisitions are ahead of plan, and the portfolio is being sharpened toward water, power, nuclear, and aerospace. The stock story is less generous: a high multiple, a 12% drawdown, and a market that may be waiting to see whether the accretion and the portfolio swap actually hold through 2027. Alex closed with the right line: “We are not finished. We continue to see attractive opportunities to further strengthen the portfolio.” — Alejandro Alcala, President and Chief Executive Officer · 2026-10-28 The February 9 Investor Day is the next checkpoint. Until then, the debate is no longer whether Crane can grow. It is what multiple a record-backlog industrial with $748 million of net debt and a fresh water-pumps acquisition deserves.